China's Sinovac kicked off a coronavirus vaccine trial in Indonesia and revealed promising data on its candidate from a mid-stage study. 

South Korea's Daewoong Pharmaceutical got a thumbs up to test a tapeworm drug against COVID-19 in India. Meanwhile, researchers at a U.S. university will test whether the antidepressant Luvox could curb cytokine storm in coronavirus patients. 

Plus, Switzerland called dibs on 200,000 doses of an experimental COVID-19 treatment from Molecular Partners, and the Serum Institute of India thinks it could have a shot ready to go by year-end, CEO Adar Poonawalla said.